A NEW APPROACH TO THE TREATMENT OF TYPE 2 DIABETES MELLITUS WITH CORONARY HEART DISEASE
Keywords:
type 2 diabetes mellitus, cardiovascular complications, empagliflozinAbstract
In modern clinical practice, type 2 diabetes mellitus therapy should be aimed not only at achieving glycemic control, but also at influencing other modified risk factors for the development of cardiovascular diseases, including hypertension, overweight, frequent hypoglycemia, etc. [4]. Empagliflozin is the first hypoglycemic drug for which a new indication has been approved for use as a means to reduce the risk of cardiovascular mortality in patients with type 2 diabetes mellitus and concomitant cardiovascular diseases.
References
Rizayeva Malika Jamolovna. “IMPROVEMENT OF METHODS OF TREATMENT OF PERSISTENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC HEART DISEASE”, IEJRD Journal, vol. 5, no. SPECIAL ISSUE, p. 7, Dec. 2020.
Pulatova Sh.Kh. Method of improving vasopressor therapy for acute myocardic infarction complied with cardiogenic shock 911. American Journal of Medicine and Medicine Sciences 2020. Vol.10. ISSN: 2165-901X http://journal.sapub.org/ajmms
Rizaeva, M. J., & Tukhtaev, D. A. (2020). FACTORS ASSOCIATED WITH THE CRISIS COURSE OF ARTERIAL HYPERTENSION. In Botkin readings (pp. 227-227).
Rizaeva, M. J. (2020). EFFICACY AND SAFETY OF ELECTRIC CARDIOVERSION IN PERSISTENT ATRIAL FIBRILLATION. New Day in Medicine, (4), pp.322-325.
Rizaeva, M. Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. European journal of molecular medicine, 2(1).
Pulatova Sh.H. Improvement of treatment of patients with acute heart failure, a comparative evaluation of the effectiveness of dobutamine and levosimendan// World Journal Of Pharmaceutical Research. 2020. Vol 9 (6). – pp. 2283-2288
Pulatova Sh.H. Method of improving vasopressor therapy for acute myocardial infarction complied with cardiogenetic shock // American Journal of Medicine and Medical Sciences. 2020.– Vol. 10 (11). – pp. 911-913
Pulatova Sh.Kh. Features of TLT in patients with acute myocardial infarction // Emergency Medicine Bulletin, Tashkent, 2019. - No. 6. - pp.89-92 (14.00.00; No. 11)
Pulatova Sh.Kh. "OPTIMIZATION OF CARDIOGENIC SHOCK TREATMENT." Uzbek
Medical Journal 3.6 (2022).
Akhmedov L.A., Pulatova Sh. H. Optimization of hemodynamic diagnosis of acute left ventricular failure // Proceedings of the 7th Eurasian Congress of Cardiology. Cardiology of Uzbekistan. 2019, С. 255.
Kenjaev Jr, Akhmedov LA, Povlatova Sh, Boboeva M.M. The course of myocardial infarction in young patients // Physicians' Information Bulletin. Tashkent, 2017.- No. 4-P. 44.
Kenjaev Jr., Akhmedov LA, Pulatova Sh., Boboeva M.M. Complication of cardioshock // Physicians' Information Bulletin on improving vasopressor therapy in the treatment of acute myocardial infarction. Tashkent, 2017.- No. 1-P. 31
Pulatova, Sh. H. (2012). Founders: Institute of Immunology of the Academy of Sciences of the Republic of Uzbekistan. THEORETICAL AND CLINICAL MEDICINE
Pulatova Sh.H. A method to improve vasopressor therapy of acute myocardial infarction accompanied by cardiogenic shock // American Medical Journal. 2020.- Vol. 10 (11). - - с. 911- 913
Pulatova Sh.H. Improvement of treatment of patients with acute heart failure, comparative evaluation of dobutamine and levosimen efficacy // World Journal of Pharmaceutical Research. 2020. Vol. 9 (6). - С. 2283-2288
Vogt A., von Essen R., Tebbe U. et al. Impact of early perfusion status of the infarct- related artery on short-term mortality after thrombolysis for acute myocardial in-farction: retrospective analysis of four German multicenter studies. // J Am Coll Cardiol 1993;21: 391—395.
